1.14.19.64	additional information	-	0.43 pmol/min/pmol P450 for the CYP719A2 variant, (R,S)-scoulerine as substrate	673579	
1.14.19.64	additional information	-	CYP719A2 variant uses only (R,S)-cheilanthifoline as substrate to produce stylopine when incubating with a mixture of 0.4 microM (R,S)-cheilanthifoline and 0.4 microM S-scoulerine as substrates	673579	
1.14.19.64	additional information	-	CYP719A3 and CYP719A2 do not react with columbamine, (R,S)-reticuline, (R,S)-norreticuline, (S)-N-methylcoclaurine, (S)-coclaurine, (R,S)-6-O-methylnorlaudanosoline and magnoflorine to make corresponding products with a methylenedioxy bridge	673579	
1.14.19.64	additional information	-	CYP719A3 but not CYP719A2 variant converts (S)-tetrahydrocolumbamine to (S)-tetrahydroberberine	673579	
1.14.19.64	additional information	-	CYP719A3 converts a mixture of 0.4 microM (R,S)-cheilanthifoline and 0.4 microM S-scoulerine as substrates to stylopine and nandinine	673579	
1.14.19.64	0.0000045	-	CYP719A3 variant, (S)-scoulerine as substrate, microsomal protein used for determination	673579